Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $541,110 | 108 | 51.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $140,689 | 41 | 13.4% |
| Travel and Lodging | $133,438 | 576 | 12.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $98,300 | 28 | 9.3% |
| Consulting Fee | $59,390 | 23 | 5.6% |
| Honoraria | $48,450 | 20 | 4.6% |
| Food and Beverage | $30,172 | 665 | 2.9% |
| Education | $156.50 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $409,101 | 367 | $0 (2024) |
| Dompe US, Inc. | $191,071 | 279 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $105,956 | 133 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $74,828 | 83 | $0 (2017) |
| Shire North American Group Inc | $64,536 | 142 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $55,869 | 138 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $53,003 | 106 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $43,127 | 70 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $40,007 | 57 | $0 (2024) |
| EYEVANCE PHARMACEUTICALS LLC | $7,073 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $243,378 | 301 | Mallinckrodt Hospital Products Inc. ($127,650) |
| 2023 | $99,728 | 145 | Mallinckrodt Hospital Products Inc. ($53,884) |
| 2022 | $179,063 | 199 | Mallinckrodt Hospital Products Inc. ($106,492) |
| 2021 | $191,025 | 263 | Mallinckrodt Hospital Products Inc. ($108,145) |
| 2020 | $18,897 | 59 | Mallinckrodt Hospital Products Inc. ($12,931) |
| 2019 | $108,655 | 157 | Mallinckrodt Enterprises LLC ($72,297) |
| 2018 | $74,827 | 125 | Bausch & Lomb, a division of Bausch Health US, LLC ($32,608) |
| 2017 | $136,131 | 218 | Valeant Pharmaceuticals North America LLC ($74,828) |
All Payment Transactions
1,467 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $348.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | Cash or cash equivalent | $80.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $85.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $46.50 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $39.87 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.40 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.20 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $375.79 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $329.15 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $292.55 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $198.20 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $85.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 461 | 757 | $157,740 | $41,240 |
| 2022 | 4 | 376 | 742 | $142,700 | $33,063 |
| 2021 | 5 | 386 | 770 | $167,490 | $39,200 |
| 2020 | 4 | 351 | 611 | $197,065 | $47,784 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 270 | 513 | $87,210 | $21,066 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 134 | $28,810 | $9,218 | 32.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 24 | 57 | $25,960 | $6,496 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $8,960 | $2,492 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $4,160 | $1,256 | 30.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,640 | $711.66 | 27.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 308 | 656 | $111,520 | $26,106 | 23.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 24 | 42 | $21,560 | $4,679 | 21.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 32 | 32 | $7,040 | $1,370 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $2,580 | $908.03 | 35.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 297 | 626 | $106,420 | $26,920 | 25.3% |
| 68761 | Closure of tear duct opening using plug | Office | 2021 | 21 | 53 | $24,640 | $5,181 | 21.0% |
| 68760 | Repair duct opening | Office | 2021 | 12 | 33 | $20,570 | $4,599 | 22.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 27 | 27 | $5,940 | $1,353 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 31 | $9,920 | $1,148 | 11.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 241 | 485 | $155,200 | $38,425 | 24.8% |
| 68760 | Repair duct opening | Office | 2020 | 13 | 29 | $17,545 | $3,789 | 21.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 64 | 64 | $13,760 | $3,677 | 26.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 33 | 33 | $10,560 | $1,893 | 17.9% |
About Dr. John Affeldt, MD
Dr. John Affeldt, MD is a Ophthalmology healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275523375.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Affeldt, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $243,378 received in 2024. These payments were reported across 1,467 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($541,110).
As a Medicare-enrolled provider, Affeldt has provided services to 1,574 Medicare beneficiaries, totaling 2,880 services with total Medicare billing of $161,288. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Loma Linda, CA
- Active Since 10/28/2005
- Last Updated 03/06/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1275523375
Products in Payments
- ACTHAR (Biological) $515,057
- OXERVATE (Drug) $174,030
- XIIDRA (Drug) $65,599
- MIEBO (Drug) $50,759
- ZYLET (Drug) $48,648
- Cequa (Drug) $39,988
- EYSUVIS (Drug) $29,304
- BESIVANCE (Drug) $22,888
- LOTEMAX GEL (Drug) $21,682
- INVELTYS (Drug) $13,928
- LOTEMAX SM (Drug) $13,511
- ALREX (Drug) $11,397
- PROLENSA (Drug) $7,275
- Flarex (Drug) $7,045
- LOTEMAX (Drug) $5,321
- Oxervate (Drug) $2,922
- BLINK NUTRITEARS (Drug) $850.00
- TYRVAYA (Drug) $642.82
- RESTASIS MULTIDOSE (Drug) $266.90
- RESTASIS (Drug) $179.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Loma Linda
Jay Mattheis, M.d, M.D
Ophthalmology — Payments: $354,051
Douglas Van Putten, Md,Facs, MD,FACS
Ophthalmology — Payments: $56,834
Leila Khazaeni, M.d, M.D
Ophthalmology — Payments: $7,673
William May, M.d, M.D
Ophthalmology — Payments: $6,353
Michael Rauser, M.d, M.D
Ophthalmology — Payments: $3,892
Dr. Safa Arfeen, Md, MD
Ophthalmology — Payments: $2,392